Brief: Intra-Cellular Therapies Reports Third Quarter Results
Nov 3 (Reuters) - Intra-Cellular Therapies Inc ITCI.O :
* Q3 REVENUE $71.9 MILLION
* INTRA-CELLULAR THERAPIES REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* QTRLY LOSS PER SHARE $0.57
* Q3 EARNINGS PER SHARE VIEW $-0.81, REVENUE VIEW $66.0
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbkpKdg
Further company coverage: ITCI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intra-Cellular Therapies
See all newsBrief: Intra-Cellular Therapies stockholder filed lawsuit against co, board in NY Supreme Court
Intra-Cellular Therapies Inc reports results for the quarter ended December 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-Apple, Caterpillar, Visa
Street View: New drug launches, ITCI deal to boost J&J's growth
J&J beats quarterly sales and profit estimates on cancer drug sales (updated)